Meeting the Needs of the Future
With the advent of personalised medicines - combined with the twin drives to reduce time-to-market and lower drug development costs - manufacturers are seeking new techniques that will let them meet the challenges ahead.
PharmaMV has been designed to provide a comprehensive toolset, purpose-built to optimise your drug development pipeline and manufacturing processes.
Pharma and biopharma organisations need integrated and fully compliant PAT tools that can deliver process monitoring, process control and crucially process optimisation for the manufacture of small molecule and biologic therapies.
From Lab to Pilot to Plant
PharmaMV is enabling Quality by Design, QbD, to speed-up API development, as well as rapid scale-up from pilot plant to manufacturing. The same platform will optimise production and deliver fully-traceable manufacturing in line with 21 CFR part 11.
Designed and built in close collaboration with development groups and manufacturing teams from many of the world's leading pharma companies, PharmaMV delivers fault-tolerant monitoring, control and optimisation of the widest possible range of production and processing assets, while ensuring ease-of-use.
So, whether you are looking to reduce API consumption at lab- or pilot-scale, optimise drug substance or drug product production at pilot plant phase, or increase yield and quality in continuous manufacturing, PharmaMV has become the software platform of choice by global pharma companies, as well as leading edge research facilities.
